Paul Guerin, DO

Paul Guerin, DO

Resident Physician
Neurology

    About me

    Gender

    Male

    Education & training

    Medical School
    Lincoln Memorial University DeBusk College of Osteopathic Medicine
    Resident Program
    Neurology
    Resident Graduation Year
    2024
    Hometown
    Winchester, TN
    Hobbies
    Golf, fishing, playing guitar.
    Interests: Epilepsy / Cognitive Disorders/ Neuropsychiatry
    Why they chose SIU

     I wanted a program with good clinical exposure, but I didn’t want a huge place that was impersonal. SIU is a great mixture of opportunity and good people. There is plenty of academic exposure, and the resident community is very collegial.

    Clinical trials

    Trial
    Neuroscience Institute

    18-513: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

    Active not recruiting

    18-513:  The purpose of this study is to evaluate the effect of andexanet alfa (andexanet) versus usual care on the rate of effective homostasis.

    Contact: Stephanie Kohlrus 217-545-3013
    Trial
    Neurology

    Portola: A Randomized Clinical Trial of Andexanet Alfa in Acute Intracranial Hemorrhage in Patients Receiving an Oral Factor XA Inhibitor

    Active not recruiting

    ANNEXa-1 (18-513): This is a randomized, multicenter clinical trial designed to determine the efficacy and safety of andexanet compared to usual care in patients presenting with acute intracerebral hemorrhage within 6 hours of symptom onset (from the baseline scan) and within 15 hours of taking an oral FXa inhibitor (from randomization). The study will use a prospective, randomized, open-label design, as it is unfeasible to blind the Investigator to the treatment assignment given the many potential therapeutic options available under usual care treatment.

    Contact: Stephanie Kohlrus 217-545-3013